89bio Inc
NASDAQ:ETNB 4:00:00 PM EDT
89bio Inc Stock, NASDAQ:ETNB
142 Sansome Street, 2nd floor, San Francisco, California 94104
United States of America
Phone: +1.415.432.9270
Number of Employees: 70
Description
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.